SEARCH RESULTS FOR: "Tag: BIIB"
loading image
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2023(3)
2022(9)
2021(7)
2020(4)
2019(15)
2018(7)
2017(14)
2016(14)
2015(15)
2014(1)
CATEGORIES
5-Minute Market Rundown(4)
Analyst Update(13)
Analyst Upgrades(3)
Buzz Stocks(37)
By the Numbers(2)
Earnings Preview(4)
Ezines(2)
General(5)
Intraday Option Activity(14)
Market Recap(1)
Midday Market Check(5)
Opening View(7)
Quantitative Analysis(2)
Stock Market News(4)
Stocks On the Move(10)
Technical Analysis(1)
The Week Ahead(1)

5/3/2023 10:59 AM
The shares of Biogen Inc (NASDAQ:BIIB) are enjoying tailwinds from positive news surrounding sector peer Eli Lilly's (LLY) Alzheimer's drug donanemab. Biogen last week reported first-quarter earnin...
4/17/2023 10:14 AM
Biogen Inc (NASDAQ:BIIB) is buzzing today, after Piper Sandler and Wedbush praised the drugmaker ahead of the company's first-quarter earnings report -- due out before the market's open on Tuesday, Ap...
1/20/2023 11:15 AM
The U.S. Food and Drug Administration (FDA) rejected the accelerated approval of Eli Lilly and Co's (NYSE:LLY) experimental Alzheimer's drug due to a lack of enough trial data from patients treated f...
12/29/2022 2:49 PM
Pharma and biotech stocks are enjoying tailwinds as part of the broad market rally today. Biogen Inc (NASDAQ:BIIB), Crispr Therapeutics AG (NASDAQ:CRSP), and also Vertex Pharmaceuticals Incorporated ...
11/28/2022 9:37 AM
Biogen Inc (NASDAQ:BIIB) is under pressure this morning, in the wake of a research paper published on Science.org this Sunday. The report indicated a 65-year-old patient receiving the experimental Al...